Literature DB >> 3079780

Sudden death and the competitive athlete: perspectives on preparticipation screening studies.

S E Epstein, B J Maron.   

Abstract

Sudden death in healthy athletes is uncommon but, when it occurs, the primary mechanism is cardiovascular. The major cause of sudden death in the young athlete is hypertrophic cardiomyopathy or related conditions characterized by left ventricular hypertrophy, aortic rupture due to cystic medial necrosis and congenital coronary artery abnormalities. In the middle-aged or older athlete, coronary artery disease is the most significant cause of sudden death. Noninvasive screening procedures are currently available that can detect most subjects at risk of sudden death. However, although some potentially lethal diseases can be excluded by a relatively simple screening program, other diseases require expensive procedures, such as echocardiography and exercise electrocardiographic stress testing. This means that the sensitivity of detecting diseases leading to sudden death increases in proportion to the financial resources that can be applied to the screening program. Thus, when a screening program designed to identify all cardiac diseases that have the potential to cause sudden death is planned by a community, school or nonprofessional athletic team, the costs will almost undoubtedly be considered prohibitive. The practicality of applying a community- or school-initiated screening program can be questioned because of the very low incidence of sudden unexpected death in young healthy individuals. It is therefore likely that comprehensive screening programs will be confined to individuals or organizations with adequate financial resources. Less expensive, limited screening can be undertaken by individuals or groups to identify some subjects at risk of sudden death during athletic competition.

Entities:  

Mesh:

Year:  1986        PMID: 3079780     DOI: 10.1016/s0735-1097(86)80285-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Reactive oxygen species and tendinopathy: do they matter?

Authors:  C S Bestwick; N Maffulli
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

Review 2.  Sudden death risk in older athletes: increasing the denominator.

Authors:  D S Tunstall Pedoe
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

3.  Refocusing the adolescent preparticipation physical evaluation toward preventive health care.

Authors:  M C Koester
Journal:  J Athl Train       Date:  1995-10       Impact factor: 2.860

Review 4.  Sudden death from cardiovascular disease in young athletes: fact or fiction?

Authors:  S Sharma; G Whyte; W J McKenna
Journal:  Br J Sports Med       Date:  1997-12       Impact factor: 13.800

Review 5.  National Athletic Trainers' Association position statement: Preparticipation physical examinations and disqualifying conditions.

Authors:  Kevin M Conley; Delmas J Bolin; Peter J Carek; Jeff G Konin; Timothy L Neal; Danielle Violette
Journal:  J Athl Train       Date:  2014 Jan-Feb       Impact factor: 2.860

Review 6.  Cardiovascular evaluation of the athlete. Issues regarding performance, screening and sudden cardiac death.

Authors:  B A Franklin; G F Fletcher; N F Gordon; T D Noakes; P A Ades; G J Balady
Journal:  Sports Med       Date:  1997-08       Impact factor: 11.136

Review 7.  Exercise and physical activity in the adult population: a general internist's perspective.

Authors:  D M Peterson
Journal:  J Gen Intern Med       Date:  1993-03       Impact factor: 5.128

Review 8.  Sudden death in athletes.

Authors:  J F Winget; M A Capeless; P A Ades
Journal:  Sports Med       Date:  1994-12       Impact factor: 11.136

9.  Pre-participation physical evaluations. Development of uniform guidelines.

Authors:  D M Smith
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

10.  A survey of the causes of sudden death in sport in the Republic of Ireland.

Authors:  F Quigley
Journal:  Br J Sports Med       Date:  2000-08       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.